Published in Vaccine Weekly, July 19th, 2006
"Recombinant proteins are used for vaccines, therapy, and diagnosis of many diseases. Biological activity of these may differ from native counterpart and needs investigation. The present study aimed to compare recombinant (r) and native (n) glutathione-S-transferase (GST) from Alternaria alternata, researchers in India report.
"Glutathione-S-transferase sequence showed an ORF of 696 bp encoding 26-kDa protein with N-terminus conserved domain," said Jay Shankar and colleagues at the Institute of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.